CYTEK BIOSCIENCES, INC. Interest Expense
CYTEK BIOSCIENCES, INC. (CTKB) reported Interest Expense of $441.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-08
- CYTEK BIOSCIENCES, INC. interest expense for the quarter ending 2024-03-31 was $441.00K, a 34.47% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense for the quarter ending 2023-12-31 was $394.00K, a 42.65% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense for the quarter ending 2023-09-30 was $595.00K, a 8.32% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense for the quarter ending 2023-06-30 was $409.00K, a 36.79% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense for fiscal 2023 was $2.07M, a 19.51% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. interest expense for fiscal 2022 was $2.57M, a 47.79% increase from fiscal 2021.
- CYTEK BIOSCIENCES, INC. interest expense for fiscal 2021 was $1.74M, a 422.82% increase from fiscal 2020.
- CYTEK BIOSCIENCES, INC. interest expense for fiscal 2020 was $333.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $441.00K 10-Q · filed 2024-05-08 | $835.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.43M derived: sum of 3 quarters · filed 2024-05-08 | $1.84M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $989.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.40M derived: sum of 3 quarters · filed 2024-03-13 | $2.07M 10-K · filed 2024-03-13 |
| 2023-09-30 | $595.00K 10-Q · filed 2023-11-14 | $1.00M derived: sum of 2 quarters · filed 2023-11-14 | $1.68M 10-Q · filed 2023-11-14 | $2.36M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $409.00K 10-Q · filed 2023-08-08 | $1.08M 10-Q · filed 2023-08-08 | $1.77M derived: sum of 3 quarters · filed 2024-05-08 | $2.42M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $673.00K 10-Q · filed 2024-05-08 | $1.36M derived: sum of 2 quarters · filed 2024-05-08 | $2.01M derived: sum of 3 quarters · filed 2024-05-08 | $2.66M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.34M derived: sum of 2 quarters · filed 2024-03-13 | $1.98M derived: sum of 3 quarters · filed 2024-03-13 | $2.57M 10-K · filed 2024-03-13 |
| 2022-09-30 | $649.00K 10-Q · filed 2023-11-14 | $1.30M derived: sum of 2 quarters · filed 2023-11-14 | $1.89M 10-Q · filed 2023-11-14 | $2.38M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $647.00K 10-Q · filed 2023-08-08 | $1.24M 10-Q · filed 2023-08-08 | $1.73M derived: sum of 3 quarters · filed 2024-03-13 | $2.17M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $590.00K 10-Q · filed 2023-05-09 | $1.08M derived: sum of 2 quarters · filed 2024-03-13 | $1.52M derived: sum of 3 quarters · filed 2024-03-13 | $1.96M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $933.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.37M derived: sum of 3 quarters · filed 2024-03-13 | $1.74M 10-K · filed 2024-03-13 |
| 2021-09-30 | $441.00K 10-Q · filed 2022-11-09 | $874.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.25M 10-Q · filed 2022-11-09 | $1.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $433.00K 10-Q · filed 2022-08-10 | $808.00K 10-Q · filed 2022-08-10 | $1.14M derived: sum of 3 quarters · filed 2023-03-01 | $1.14M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $375.00K 10-Q · filed 2022-05-12 | $705.00K derived: sum of 2 quarters · filed 2023-03-01 | $707.00K derived: sum of 3 quarters · filed 2023-03-01 | $708.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $332.00K derived: sum of 2 quarters · filed 2023-03-01 | $333.00K derived: sum of 3 quarters · filed 2023-03-01 | $333.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-12 | $3.00K derived: sum of 2 quarters · filed 2021-11-12 | $3.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.00K 10-Q · filed 2021-09-03 | $1.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |